Medical/Pharmaceuticals
Funding secured for CE approval of the groundbreaking C-MIC device from Berlin Heals Holding AG
ZUG, Switzerland, June 17, 2024 /PRNewswire/ -- The Berlin Heals Holding AG has developed the C-MIC device, a revolutionary and life-saving treatment for patients with heart failure (DCM / dilated cardiomyopathy). The patented technology is easily implantable and has shown unprecedented clinic...
2024-06-17 16:00
2408
Faculty of Medicine Siriraj Hospital and Dhulikhel Hospital commemorate 15 years of collaborative relationship
BANGKOK, June 17, 2024 /PRNewswire/ -- In 2024, Thai-Nepalese bilateral relations reached a new milestone as the Faculty of Medicine Siriraj Hospital at Mahidol University inThailand and Dhulikhel Hospital at Kathmandu University inNepal celebrated the 15th anniversary of their esteemed partnersh...
2024-06-17 15:04
2593
ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research
International scientific meeting convenes in Bangkok, Thailand, for the first time highlighting the important work of the Asian-Pacific scientific and clinical community BANGKOK, June 17, 2024 /PRNewswire/ -- Today, the International Society on Thrombosis and Haemostasis (ISTH) announces that al...
2024-06-17 10:00
2744
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024
SHANGHAI and NANJING, China and SAN JOSE, Calif., June 15, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equec...
2024-06-15 22:30
4402
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024
SHANGHAI, June 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the initial results from the ongoing first-in-human study of CT0...
2024-06-15 20:50
4241
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
* Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other thanChina and a few other areas. * Ascentage Pharma to receive an option payment of 100 million USD upon closing and be eligible for an option exercise fee and additional potential m...
2024-06-14 21:30
9884
Thailand BOI Approves Investment Worth USD1.54 billion in Biochemicals, Data Centers, and Hospital; Sets New Promotion Category for the Repair of Used EV Batteries and ESS
BANGKOK, June 14, 2024 /PRNewswire/ -- The Thailand Board of Investment (BOI) today approved the investment promotion applications of eight large projects worth a combined56.95 billion baht (USD 1.54 billion), including a bio-ethylene plant project by the local joint venture ofBrazil's Braskem, a...
2024-06-14 15:28
4055
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
HANGZHOU, China, June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced today that its in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, Venus...
2024-06-14 15:15
3653
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
SAN FRANCISCO and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology ...
2024-06-14 08:34
7718
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
SAINT-CLOUD, France, June 13, 2024 /PRNewswire/ -- Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from the Chinese Company Jiangsu Anbison Pharmaceutical. Leader in essential medicines for cen...
2024-06-13 22:33
2797
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 13, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that th...
2024-06-13 18:03
3904
NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore
* Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearlyUS$400 million funding in total alongside significant business milestones * The Eppendorf Group has signed a partnership agr...
2024-06-13 10:00
4409
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 13, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2024-06-13 08:00
5507
Amplify Healthcare Documentation: New AI-Powered Clinical Workflow Solution Incorporating Dragon Medical Capabilities
LONDON, June 13, 2024 /PRNewswire/ -- Prescribe Digital, a pioneering leader in healthcare technology, proudly introduces its AI-powered clinical documentation workflow solution, designed to elevate the efficiency of healthcare professionals grappling with the ever-increasing demands of accurate ...
2024-06-13 08:00
3019
Aesthetic procedures close to 35 million in 2023
Total surgical and non-surgical procedures increased by 3.4% in 2023, up to 34.9 million. MOUNT ROYAL, N.J., June 13, 2024 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures this week a...
2024-06-13 05:00
3300
Ansell Recognized with the Frost & Sullivan 2024 Global Company of the Year Award for Revolutionizing Workplace Safety and Promoting Sustainability
Ansell is committed to ensuring the safety and well-being of workers worldwide with an extensive range of safety solutions that meet the specific needs of clinicians and healthcare providers. SAN ANTONIO, June 12, 2024 /PRNewswire/ -- Frost & Sullivan recently researched and conducted a review o...
2024-06-12 21:00
2296
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, June 12, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
2024-06-12 19:51
2705
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, June 12, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
2024-06-12 19:51
3283
2024ASCO｜Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations
Introduction: ADC Drug Breakthrough Targets TF in Pancreatic Cancer CHICAGO, June 12, 2024 /PRNewswire/ -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, held inChicago from May 31 to June 4, shone a spotlight on MRG004A, a novel antibody-drug conjugate (ADC) designed to tr...
2024-06-12 19:31
2012
Growth market USA: Exyte plans to create up to 1,000 new jobs in high-tech facility industry
* Exyte to create up to 1,000 jobs in target industries across the USA to facilitate growth * Further expansion of service and production network in the USA * With official opening of new office in Boise, Idaho, Exyte expands to the Northwest * Exyte CEO Büchele: "Given its high market pot...
2024-06-12 19:13
2208
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 308 media titles]
2026-03-18 12:00
The Mastercard Collection: Savor the Extraordinary with Mastercard's Asia Gourmet Circle Program
[Picked up by 295 media titles]
2026-03-12 09:00Five Breakthrough AV Technologies: Dreame's Premium AV Brand INNIX Highlights a High-End Home Cinema Lineup at AWE 2026
[Picked up by 284 media titles]
2026-03-13 16:08
Travel providers to accept UnionPay cards for both direct e-Commerce bookings and in-direct sales via Amadeus Travel Platform
[Picked up by 283 media titles]
2026-03-12 11:00
Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 280 media titles]
2026-03-18 08:00
Most Read
HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations
2026-03-13 21:30
7164
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026-03-13 21:59
6668